Vonoprazan-based rescue eradication therapy for patients who have ever failed in the eradication of Helicobacter pylori

被引：0
|
作者：
Furuta, T. [1 ]
Ichikawa, H. [1 ]
Kagami, T. [1 ]
Suzuki, T. [1 ]
Yamade, M. [1 ]
Hamaya, Y. [1 ]
Iwaizumi, M. [1 ]
Osawa, S. [1 ]
Sugimoto, K. [1 ]
机构：
[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka, Japan
来源：
HELICOBACTER | 2016年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W3.3
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [21] The safety and effectiveness of vonoprazan-based Helicobacter pylori eradication therapy; a prospective post-marketing surveillance
    Ashida, Kiyoshi
    Honda, Youichirou
    Sanada, Katsuyuki
    Takemura, Yukiko
    Sakamoto, Shigeru
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (12) : 1255 - 1261
  • [22] An Analysis of the High Eradication Rate for Vonoprazan-Based Triple Therapy Against Helicobacter pylori Resistant to Clarithromycin
    Ohta, Hidetoshi
    Sagawa, Tamotsu
    GASTROENTEROLOGY, 2016, 150 (04) : S677 - S677
  • [23] Research trends on vonoprazan-based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023
    Du, Ren-Chun
    Ouyang, Yao-Bin
    Lu, Nong-Hua
    Hu, Yi
    HELICOBACTER, 2023, 28 (05)
  • [24] Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection
    Yu, Jing
    Lv, Yi-Ming
    Yang, Peng
    Jiang, Yi-Zhou
    Qin, Xiang-Rong
    Wang, Xiao-Yong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (20) : 3133 - 3144
  • [25] Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection
    Jing Yu
    Yi-Ming Lv
    Peng Yang
    Yi-Zhou Jiang
    Xiang-Rong Qin
    Xiao-Yong Wang
    World Journal of Gastroenterology, 2023, (20) : 3133 - 3144
  • [26] Vonoprazan Dual and Triple Therapy for Helicobacter pylori Eradication
    Chey, William D.
    Megraud, Francis
    Laine, Loren
    Lopez, Luis J.
    Hunt, Barbara
    Smith, Neila
    Leifke, Eckhard
    Knipfer, Nancianne
    Howden, Colin W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S634 - S634
  • [27] Vonoprazan-based third-line triple therapy in Helicobacter pylori eradication and study of the diversity of antimicrobial susceptibilities
    Yano, Yukari
    Mizuta, Hiroshi
    Ono, Masafumi
    Nagano, Sho
    Tsuda, Hisako
    Kitagawa, Tatsuya
    Hashiba, Motoi
    Okamoto, Nobuto
    Kira, Mizuki
    Takeuchi, Hiroaki
    Matsumura, Yoshihisa
    Saibara, Toshiji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 95 - 95
  • [28] Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study
    Kakiuchi, Toshihiko
    Matsuo, Muneaki
    Endo, Hiroyoshi
    Sakata, Yasuhisa
    Esaki, Motohiro
    Noda, Takahiro
    Imamura, Ichiro
    Hashiguchi, Kazutoshi
    Ogata, Shinichi
    Fujioka, Yasuhiko
    Hanada, Keiichiro
    Fukuda, Kayoko
    Yoshimura, Masaya
    Kajiwara, Tetsuro
    Yamamoto, Kentaroh
    Yamaguchi, Daisuke
    Kawakubo, Hiroharu
    Matsunaga, Takuya
    Sumino, Michihiro
    Matsunaga, Keiji
    Muro, Eriko
    Watanabe, Akira
    Fujimoto, Kazuma
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (03) : 196 - 204
  • [29] Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
    Sugimoto, Mitsushige
    Yamaoka, Yoshio
    FRONTIERS IN PHARMACOLOGY, 2019, 9
  • [30] Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy
    Kawashima, Kousaku
    Ishihara, Shunji
    Kinoshita, Yoshikazu
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (06) : 688 - 689
12345